Browsing Tag
European Commission
244 posts
Chvaletice Manganese Project : Euro Manganese seeks strategic project status under EU’s Critical Raw Materials Act
Euro Manganese Inc. has officially submitted an application to secure Strategic Project status for its Chvaletice Manganese Project…
EC approves PADCEV and KEYTRUDA combo for advanced urothelial cancer treatment
Astellas Pharma Inc. has announced a significant milestone in cancer treatment with the European Commission (EC’s) approval of…
Avanzanite Bioscience secures EC approval for AKANTIOR as first authorised treatment for acanthamoeba keratitis
The European Commission (EC) has granted marketing authorisation for AKANTIOR (polihexanide), the first and only approved treatment for…
Dresden to become semiconductor powerhouse: EU approves massive €5bn funding
The European Commission has endorsed a €5 billion state aid measure for the European Semiconductor Manufacturing Company (ESMC),…
AbbVie and Genmab’s TEPKINLY approved by EC for advanced lymphoma
AbbVie (NYSE: ABBV) and Genmab (NASDAQ: GMAB) have announced that the European Commission (EC) has granted conditional marketing…
EC approves Bunge’s $34bn acquisition of Viterra with conditions
The European Commission (EC) has granted unconditional approval for Bunge Global S.A.’s acquisition of Viterra Limited, a deal…
EC approves Hewlett Packard Enterprise’s acquisition of Juniper Networks
The European Commission (EC) has granted unconditional approval for Hewlett Packard Enterprise Company (HPE) to acquire Juniper Networks,…
Johnson & Johnson’s TB drug SIRTURO receives full approval from FDA and EC
In a significant development for the treatment of drug-resistant tuberculosis (TB), Johnson & Johnson has announced that SIRTURO…
EC endorses €10.8 French offshore wind energy scheme
The European Commission (EC) has granted approval for a monumental €10.82 billion scheme to support France’s ambitious offshore…
Voydeya approved in EU for enhanced treatment of PNH with residual haemolytic anaemia
Voydeya (danicopan), a first-in-class oral Factor D inhibitor from Alexion, AstraZeneca Rare Disease, has received approval from the…